| Patent | Date |
|---|
Abuse-resistant Pharmaceutical Compositions
App 20140112980 - Vaghefi; Farid ; et al. | 2014-04-24 |
Abuse-resistant pharmaceutical compositions
Grant 8,623,412 - Farid , et al. January 7, 2 | 2014-01-07 |
Controlled Release Nanoparticulate Compositions
App 20130011447 - Swanson; Jon ; et al. | 2013-01-10 |
Nanoparticulate quinazoline derivative formulations
Grant 8,309,133 - Liversidge , et al. November 13, 2 | 2012-11-13 |
Glipizide compositions
Grant 8,236,352 - Bosch , et al. August 7, 2 | 2012-08-07 |
Nanoparticulate Bisphosphonate Compositions
App 20120128780 - Liversidge; Gary G. ; et al. | 2012-05-24 |
Novel mometasone compositions and methods of making and using the same
App 20120121653 - Jenkins; Scott ; et al. | 2012-05-17 |
Nanoparticulate bisphosphonate compositions
Grant 8,158,153 - Liversidge , et al. April 17, 2 | 2012-04-17 |
Nanoparticulate statin formulations and novel statin combinations
App 20110027371 - Cooper; Eugene R. ; et al. | 2011-02-03 |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
Grant RE41,884 - de Garavilla , et al. October 26, 2 | 2010-10-26 |
Nanoparticulate azelnidipine formulations
App 20100221327 - Jenkins; Scott ; et al. | 2010-09-02 |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
Grant 7,763,278 - Cooper , et al. July 27, 2 | 2010-07-27 |
Nanoparticulate Polycosanol Formulations & Novel Polycosanol Combinations
App 20100143962 - COOPER; Eugene R. ; et al. | 2010-06-10 |
Nanoparticulate stabilized anti-hypertensive compositions
App 20100028439 - Jenkins; Scott ; et al. | 2010-02-04 |
Nanoparticulate Anticonvulsant And Immunosuppressive Compositions
App 20090297619 - Swanson; Jon ; et al. | 2009-12-03 |
Nanoparticulate Tacrolimus Formulations
App 20090252806 - JENKINS; Scott ; et al. | 2009-10-08 |
Nanoparticulate statin formulations and novel statin combinations
App 20080213378 - Cooper; Eugene R. ; et al. | 2008-09-04 |
Zonisamide And Nsaid Nanoparticulate Formulations
App 20070134339 - Jenkins; Scott ; et al. | 2007-06-14 |
Methods of making and using novel griseofulvin compositions
App 20070098805 - Liversidge; Gary G. | 2007-05-03 |
Nanoparticulate ebastine formulations
App 20070059371 - Liversidge; Gary G. ; et al. | 2007-03-15 |
Nanoparticulate benidipine compositions
App 20070042049 - Liversidge; Gary G. ; et al. | 2007-02-22 |
Nanoparticulate clarithromycin formulations
App 20070015719 - Jenkins; Scott ; et al. | 2007-01-18 |
Nanoparticulate clopidogrel formulations
App 20070003628 - Liversidge; Gary G. ; et al. | 2007-01-04 |
Nanoparticulate clopidogrel and aspirin combination formulations
App 20070003615 - Jenkins; Scott ; et al. | 2007-01-04 |
Nanoparticulate acetaminophen formulations
App 20060292214 - Jenkins; Scott ; et al. | 2006-12-28 |
Nanoparticulate imatinib mesylate formulations
App 20060275372 - Jenkins; Scott ; et al. | 2006-12-07 |
Nanoparticulate lipase inhibitor formulations
App 20060246141 - Liversidge; Gary G. ; et al. | 2006-11-02 |
Nanoparticulate quinazoline derivative formulations
App 20060246142 - Liversidge; Gary G. ; et al. | 2006-11-02 |
Injectable compositions of nanoparticulate immunosuppressive compounds
App 20060210638 - Liversidge; Gary G. ; et al. | 2006-09-21 |
Nanoparticulate bisphosphonate compositions
App 20060210639 - Liversidge; Gary G. ; et al. | 2006-09-21 |
Abuse-resistant pharmaceutical compositions
App 20060104909 - Vaghefi; Farid ; et al. | 2006-05-18 |
Novel griseofulvin compositions
App 20050004049 - Liversidge, Gary G. | 2005-01-06 |
Milling microgram quantities of nanoparticulate candidate compounds
App 20040173696 - Cunningham, James ; et al. | 2004-09-09 |
Nanoparticulate sterol formulations and novel sterol combinations
App 20040033202 - Cooper, Eugene R. ; et al. | 2004-02-19 |
Nanoparticulate polycosanol formulations & novel polycosanol combinations
App 20030232796 - Cooper, Eugene R. ; et al. | 2003-12-18 |
Formulations for therapeutic agents absorbed through mucous membranes
App 20030054045 - Liversidge, Gary G. ; et al. | 2003-03-20 |
Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract
Grant 6,432,381 - Liversidge , et al. August 13, 2 | 2002-08-13 |
Formulations For Therapeutic Agents Absorbed Through Mucous Membranes
App 20010006617 - LIVERSIDGE, GARY G. ; et al. | 2001-07-05 |
Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors
Grant 6,221,400 - Liversidge , et al. April 24, 2 | 2001-04-24 |
Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
Grant 6,068,858 - Liversidge , et al. May 30, 2 | 2000-05-30 |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
Grant 6,045,829 - Liversidge , et al. April 4, 2 | 2000-04-04 |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
Grant 5,834,025 - de Garavilla , et al. November 10, 1 | 1998-11-10 |
Surface modified NSAID nanoparticles
Grant 5,552,160 - Liversidge , et al. September 3, 1 | 1996-09-03 |
Surface modified anticancer nanoparticles
Grant 5,494,683 - Liversidge , et al. February 27, 1 | 1996-02-27 |
X-ray contrast compositions useful in medical imaging
Grant 5,451,393 - Liversidge , et al. September 19, 1 | 1995-09-19 |
Surface modified anticancer nanoparticles
Grant 5,399,363 - Liversidge , et al. March 21, 1 | 1995-03-21 |
X-ray contrast compositions useful in medical imaging
Grant 5,318,767 - Liversidge , et al. June 7, 1 | 1994-06-07 |
Method to reduce particle size growth during lyophilization
Grant 5,302,401 - Liversidge , et al. April 12, 1 | 1994-04-12 |
Surface modified drug nanoparticles
Grant 5,145,684 - Liversidge , et al. Sep | 1992-09-08 |
| 